Evaluate Vantage: Aduhelm approval amplifies amyloid assays

Uncategorized
Written By Joni Henderson

Biogen needs blood tests for amyloid beta to progress quickly – and several are in the pipeline.

Read more

Joni Henderson
Previous

HEC-TV: St. Louis-Based C₂N Diagnostics has a Blood Test for Alzheimer’s Disease That’s Now in the Market
Next

360Dx: C₂N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space